MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-37-0019731
Basdils Pharmaceuticals Private Limited
Basdils Pharmaceuticals Private Limited - trading in Hajipur, Bihar, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹10 Lakh
▲ 2098% YoY
Net loss · FY 2024
₹21,494
Net margin -2.1%
EBITDA · FY 2024
-₹15,320
EBITDA margin -1.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Basdils Pharmaceuticals Private Limited
Data last updated:
Basdils Pharmaceuticals Private Limited is a private limited company based in Hajipur, Bihar, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 20 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2017PTC033368. Its GSTIN is 10AAHCB0874B1ZD (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Basant Kumar Singh (Managing Director) and Dilasa Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – Dilasa Kumari W/O – Dr. Basant Kumar Singh Bagmali Bari Jagdamba Asthan, Hajipur, Bihar, India – 844101.
As per the financials filed for FY 2024, the company reported a revenue of ₹10 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹21,494 (net margin -2.1%) and EBITDA of -₹15,320 (EBITDA margin -1.5%).
Basdils Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-37-0019731). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Basdils Pharmaceuticals Private Limited
CIN U51909BR2017PTC033368
Registration Number 033368
Incorporation Date 20 January 2017
ROC Patna
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-BR-37-0019731
Recognitions & Rankings of Basdils Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O – Dilasa Kumari W/O – Dr. Basant Kumar Singh Bagmali Bari Jagdamba Asthan, Hajipur, Bihar, India – 844101
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Basdils Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Basdils Pharmaceuticals Private Limited
The main business activity of Basdils Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Basdils Pharmaceuticals Private Limited FY 2025 filings available
Basdils Pharmaceuticals Private Limited reported revenue of ₹10 Lakh (up 2098% YoY) for FY 2024.
Revenue · FY 2024
₹10 Lakh ▲ 2098%
Net loss · FY 2024
₹21,494 margin -2.1%
EBITDA · FY 2024
-₹15,320 margin -1.5%
Financial Statement Summary of Basdils Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹15,320 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹21,494 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Basdils Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Basdils Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Basdils Pharmaceuticals Private Limited
Basdils Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Basant Kumar Singh | Managing Director | 20 Jan 2017 | 9 Years 9 Months | Current |
| Dilasa Kumari | Director | 20 Jan 2017 | 9 Years 9 Months | Current |
Peer Comparison of Basdils Pharmaceuticals Private Limited
Basdils Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pragyay Pharmaceuticals Private Limited | ₹10.14 Lakh (FY 2024) | •••• | •••• | 21.0% | •••• | Faizabad, Uttar Pradesh, India |
| Sarvlife Pharmaceuticals Private Limited | ₹10.1 Lakh (FY 2020) | •••• | •••• | -51.0% | •••• | Faridkot, Punjab, India |
| Dhanraj Sugars and Pharmaceuticals Private Limited | ₹10.09 Lakh (FY 2025) | •••• | •••• | 206.0% | •••• | Surendranagar, Gujarat, India |
| Amitex Pharmaceuticals Private Limited | ₹10.07 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Lucknow, Uttar Pradesh, India |
| Ny Med Pharmaceuticals Private Limited | ₹10.04 Lakh (FY 2024) | •••• | •••• | 440.0% | •••• | Delhi, India |
| Basdils Pharmaceuticals Private Limited this company | ₹10 Lakh (FY 2024) | •••• | •••• | 2098.0% | •••• | Hajipur, Bihar, India |
| Scinex Pharmaceuticals Private Limited | ₹10 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Cibien Drugs and Pharmaceuticals Pvt Ltd | ₹9.98 Lakh (FY 2025) | •••• | •••• | 455.0% | •••• | Mumbai, Maharashtra, India |
| Catkin Pharmaceuticals Private Limited | ₹9.96 Lakh (FY 2025) | •••• | •••• | -16.0% | •••• | Dehradun, Uttarakhand, India |
| Norwest Pharmaceuticals Private Limited | ₹9.95 Lakh (FY 2025) | •••• | •••• | 25.0% | •••• | New Delhi, Delhi, India |
| Sunventies Pharmaceuticals Private Limited | ₹9.94 Lakh (FY 2025) | •••• | •••• | 266.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Basdils Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Basdils Pharmaceuticals Private Limited
Basdils Pharmaceuticals Private Limited is audited by SHRAWAN KUMAR AND ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHRAWAN KUMAR AND ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Basdils Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Basdils Pharmaceuticals Private Limited
Basdils Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Basdils Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Basdils Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Basdils Pharmaceuticals Private Limited
Basdils Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Basant Kumar Singh was appointed as Managing Director on 20 Jan 2017.
AGM
Basdils Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Basdils Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Patna.
Appointed
Basant Kumar Singh was appointed as Managing Director.
Appointed
Dilasa Kumari was appointed as Director.
Incorporation
20 Jan 2017
Basdils Pharmaceuticals Private Limited was registered on 20 Jan 2017 with Roc Patna & aged 9 years 9 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Basdils Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Basdils Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Basdils Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Basdils Pharmaceuticals Private Limited
Basdils Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCB0874B1ZD | Bihar | Active | 02 Feb 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Basdils Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Basdils Pharmaceuticals Private Limited
Basdils Pharmaceuticals is an active private limited company based in Hajipur, Bihar, India. The company works in specialty, within the trading industry. It was incorporated on 20 January 2017 (9+ years old) and is registered under CIN U51909BR2017PTC033368.
Basdils Pharmaceuticals reported revenue of ₹10 Lakh for FY 2024 (up 2098% YoY).
Basdils Pharmaceuticals has 2 current directors:
- Basant Kumar Singh - Managing Director
- Dilasa Kumari - Director
Basdils Pharmaceuticals reported a net loss of ₹21,494 (net margin -2.1%) and EBITDA of -₹15,320 (EBITDA margin -1.5%) for FY 2024, as per its filed financial statements.
The GSTIN of Basdils Pharmaceuticals is 10AAHCB0874B1ZD, registered in Bihar.
The CIN (Corporate Identification Number) of Basdils Pharmaceuticals is U51909BR2017PTC033368. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Basdils Pharmaceuticals was incorporated on 20 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Basdils Pharmaceuticals by revenue are Pragyay Pharmaceuticals Private Limited, Sarvlife Pharmaceuticals Private Limited, Dhanraj Sugars and Pharmaceuticals Private Limited, Amitex Pharmaceuticals Private Limited, Ny Med Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Basant Kumar Singh was appointed as Managing Director on 20 Jan 2017. Dilasa Kumari was appointed as Director on 20 Jan 2017.
Yes, Basdils Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-37-0019731).
The registered office of Basdils Pharmaceuticals is at CO – Dilasa Kumari WO – Dr. Basant Kumar Singh Bagmali Bari Jagdamba Asthan, Hajipur, Bihar, India – 844101.